Literature DB >> 1452288

Pharmacology of smooth muscle cell replication.

C L Jackson1, S M Schwartz.   

Abstract

The suggestion that smooth muscle cell proliferation contributes to hypertension, atherosclerosis, and restenosis after angioplasty has led to a growing interest in the use of drugs to inhibit this process. This review summarizes pharmacological studies of smooth muscle cell proliferation in vitro and in vivo and identifies specific mediators of proliferation that are implicated by drugs binding with high affinity to enzymes or receptors.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1452288     DOI： 10.1161/01.hyp.20.6.713

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


  26 in total

1.  Dynamics of Vascular Remodeling: An Overview and Bibliography.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

Review 2.  Egr-1 is a major vascular pathogenic transcription factor in atherosclerosis and restenosis.

Authors:  Florian Blaschke; Dennis Bruemmer; Ronald E Law
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

3.  Deletion of the neuropeptide Y (NPY) Y1 receptor gene reveals a regulatory role of NPY on catecholamine synthesis and secretion.

Authors:  Cláudia Cavadas; Daniel Céfai; Joana Rosmaninho-Salgado; Maria Augusta Vieira-Coelho; Eduardo Moura; Nathalie Busso; Thierry Pedrazzini; Daniela Grand; Samuel Rotman; Bernard Waeber; Jean-François Aubert; Eric Grouzmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-23       Impact factor: 11.205

4.  Mechanism of action of the inhibitory effect of nifedipine on the growth of cultured aortic cells from spontaneously hypertensive and normotensive rats.

Authors:  T Hérembert; D L Zhu; P Marche
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

Review 5.  Endothelium: the main actor in the remodelling of the retinal microvasculature in diabetes.

Authors:  M Porta
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

6.  Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors.

Authors:  R K Dubey; E K Jackson; T F Lüscher
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

7.  Evidence for prostacyclin and cAMP upregulation by bradykinin and insulin-like growth factor 1 in vascular smooth muscle cells.

Authors:  Jerry G Webb; Yan Tan; Miran A Jaffa; Ayad A Jaffa
Journal:  J Recept Signal Transduct Res       Date:  2010-04       Impact factor: 2.092

8.  Influence of serum cholesterol on atherogenesis and intimal hyperplasia after angioplasty: inhibition by amlodipine.

Authors:  Mark B Kahn; Kathleen Boesze-Battaglia; David W Stepp; Artium Petrov; Yong Huang; R Preston Mason; Thomas N Tulenko
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-09-23       Impact factor: 4.733

9.  Role of E2F1-cyclin E1-cyclin E2 circuit in human coronary smooth muscle cell proliferation and therapeutic potential of its downregulation by siRNAs.

Authors:  Barbara Dapas; Rossella Farra; Mario Grassi; Carlo Giansante; Nicola Fiotti; Laura Uxa; Giuseppe Rainaldi; Alberto Mercatanti; Alfonso Colombatti; Paola Spessotto; Valentina Lacovich; Gianfranco Guarnieri; Gabriele Grassi
Journal:  Mol Med       Date:  2009-06-25       Impact factor: 6.354

10.  UAP56 is an important mediator of angiotensin II/platelet derived growth factor induced vascular smooth muscle cell DNA synthesis and proliferation.

Authors:  Abha Sahni; Nadan Wang; Jeffrey Alexis
Journal:  Biochem Biophys Res Commun       Date:  2012-12-12       Impact factor: 3.575
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.